Pharming Group N.V.（PHAR）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-08-13 | 6-K | — | SEC |
| 2026-07-30 | 6-K | — | SEC |
| 2026-06-04 | 6-K | — | SEC |
| 2026-05-28 | 6-K | — | SEC |
| 2026-05-22 | 6-K | — | SEC |
| 2026-05-07 | 6-K | — | SEC |
| 2026-05-07 | 6-K | — | SEC |
| 2026-04-16 | 6-K | — | SEC |
| 2026-04-02 | 6-K | — | SEC |
| 2026-03-27 | 6-K | — | SEC |
| 2026-03-24 | 6-K | — | SEC |
| 2026-03-12 | 6-K | — | SEC |
| 2026-02-03 | 6-K | — | SEC |
| 2026-02-02 | 6-K | — | SEC |
| 2026-01-08 | 6-K | — | SEC |
| 2025-11-06 | 6-K | — | SEC |
| 2025-10-22 | 6-K | — | SEC |
| 2025-10-06 | 6-K | — | SEC |
| 2025-10-01 | 6-K | — | SEC |
| 2025-09-10 | 6-K | — | SEC |
| 2025-09-02 | 6-K | — | SEC |
| 2025-07-31 | 6-K | — | SEC |
| 2025-06-24 | 6-K | — | SEC |
| 2025-06-11 | 6-K | — | SEC |
| 2025-05-08 | 6-K | — | SEC |
| 2025-04-30 | 6-K | — | SEC |
| 2025-04-25 | 6-K | — | SEC |
| 2025-04-23 | 6-K | — | SEC |
| 2025-04-03 | 6-K | — | SEC |
| 2025-03-20 | 6-K | — | SEC |
| 2025-03-13 | 6-K | — | SEC |
| 2025-03-04 | 6-K | — | SEC |
| 2025-02-20 | 6-K | — | SEC |
| 2025-02-07 | 6-K | — | SEC |
| 2025-01-21 | 6-K | — | SEC |
| 2025-01-21 | 6-K | — | SEC |
| 2024-12-16 | 6-K | — | SEC |
| 2024-12-11 | 6-K | — | SEC |
| 2024-10-24 | 6-K | — | SEC |
| 2024-10-10 | 6-K | — | SEC |
| 2024-09-26 | 6-K | — | SEC |
| 2024-08-01 | 6-K | — | SEC |
| 2024-05-30 | 6-K | — | SEC |
| 2024-05-21 | 6-K | — | SEC |
| 2024-05-15 | 6-K | — | SEC |
| 2024-05-08 | 6-K | — | SEC |
| 2024-04-25 | 6-K | — | SEC |
| 2024-04-24 | 6-K | — | SEC |
| 2024-04-08 | 6-K | — | SEC |
| 2024-04-04 | 6-K | — | SEC |
| 2024-03-14 | 6-K | — | SEC |
| 2024-01-08 | 6-K | — | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。